ISRAEL HODISH
Medical Practice in Ann Arbor, MI

License number
Michigan 4301085200
Issued Date
Aug 7, 2007
Expiration Date
Jan 31, 2020
Category
Medicine
Type
Medical Doctor
Address
Address
Ann Arbor, MI 48109

Personal information

See more information about ISRAEL HODISH at radaris.com
Name
Address
Phone
Israel Hodish
3236 Monument, Ann Arbor, MI 48108
Israel Hodish
Ann Arbor, MI
(734) 369-3323
Israel M Hodish
3236 Monument, Ann Arbor, MI 48108
(734) 369-3323

Organization information

See more information about ISRAEL HODISH at bizstanding.com

Israel Hodish MD,PHD

400 E Eisenhower Pkwy, Ann Arbor, MI 48108

Industry:
Internist
Phone:
(734) 647-5871 (Phone)
Israel Hodish

Professional information

Israel Hodish Photo 1

Israel Hodish, Ann Arbor MI

Work:
Ann Arbor Veterans Affairs Medical Center
2215 Fuller Rd, Ann Arbor, MI 48105 Regents of the University of Michigan
24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109


Israel Hodish Photo 2

Dr. Israel Hodish, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism
Address:
University Michigan Health END
24 Frank Lloyd Wright Dr, Ann Arbor 48105
(734) 647-5871 (Phone)
Languages:
English
Hospitals:
University Michigan Health END
24 Frank Lloyd Wright Dr, Ann Arbor 48105
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109


Israel Hodish Photo 3

Israel Hodish, Ann Arbor MI

Specialties:
Internist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
3621 S State St, Ann Arbor, MI 48108


Israel Hodish Photo 4

Apparatus For Optimizing A Patient's Insulin Dosage Regimen

US Patent:
8600682, Dec 3, 2013
Filed:
Apr 3, 2009
Appl. No.:
12/417955
Inventors:
Eran Bashan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
Assignee:
Hygieia, Inc. - Ann Arbor MI
International Classification:
G01N 33/48, G01N 31/00, G06G 7/48, G06G 7/58, A61B 5/00
US Classification:
702 19, 702 22, 703 11, 703 12, 600347, 600365
Abstract:
An apparatus for optimizing a patient's insulin dosage regimen over time, comprising: at least a first computer-readable memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; a processor operatively connected to the at least first computer-readable memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range; and a display operative to display information corresponding to at least the patient's present insulin dosage regimen.


Israel Hodish Photo 5

Apparatus And System For Diabetes Management

US Patent:
2011027, Nov 10, 2011
Filed:
Nov 11, 2009
Appl. No.:
13/128358
Inventors:
Eran Bashan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
International Classification:
A61M 5/31
US Classification:
604 66
Abstract:
An apparatus and system diabetes management. The apparatus comprises a body which houses: (i) at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; (ii) a processor operatively connected to the at least first memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen; (iii) a display screen operatively connected to the processor; (iv) a quantity of insulin; (v) a needle communicating with the quantity of insulin for delivering insulin to the patient; (vi) means for effecting delivery of a portion of the quantity of insulin to the patient via the needle; and (vii) metering means for controlling the portion of the quantity of insulin delivered to the patient via the needle.


Israel Hodish Photo 6

Systems, Methods And Devices For Achieving Glycemic Balance

US Patent:
2011031, Dec 29, 2011
Filed:
Jun 24, 2011
Appl. No.:
13/168659
Inventors:
Eran Bashan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
Assignee:
Hygieia, Inc. - Ann Arbor MI
International Classification:
A61K 38/28, A61P 3/10
US Classification:
514 59
Abstract:
Systems, methods and/or devices for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen. Also disclosed are systems, methods and/or devices for treating a patient's diabetes by providing treatment guidance, wherein the patient's current glycemic state is determined relative to a desired balance point; and determining from at least one of a plurality of the data corresponding to the patient's blood glucose-level measurements whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen to get closer to the patient's desired balance point; wherein the desired balance point is the patient's lowest blood glucose-level within a predetermined range achievable before increasing the frequency of hypoglycemic events above a predetermined threshold.


Israel Hodish Photo 7

Apparatus And Methods For Taking Blood Glucose Measurements And Recommending Insulin Doses

US Patent:
2011015, Jun 23, 2011
Filed:
Nov 3, 2010
Appl. No.:
12/926234
Inventors:
Holly Bielawa - Ann Arbor MI, US
Carissa Demetris - Ann Arbor MI, US
Carol Treat Morton - Bloomfield Township MI, US
Michelle Pomorski - Pinckney MI, US
Thomas Puricelli - Ann Arbor MI, US
James Rodgers - Ann Arbor MI, US
Eran Bashan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
John R. Hindinger - Farmington Hills MI, US
International Classification:
A61B 5/157
US Classification:
600365
Abstract:
The present disclosure related to an apparatus that may be used for taking blood glucose measurements and providing individualized insulin dose recommendations wherein the apparatus is easy to use and facilitates improved diabetes control in patients. Also disclosed are related methods.


Israel Hodish Photo 8

System For Optimizing A Patient's Insulin Dosage Regimen

US Patent:
2012002, Jan 26, 2012
Filed:
Oct 3, 2011
Appl. No.:
13/251356
Inventors:
Eran Bashan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
Assignee:
Hygieia, Inc. - Ann Arbor MI
International Classification:
A61B 5/00
US Classification:
600365
Abstract:
A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.


Israel Hodish Photo 9

System For Optimizing A Patient's Insulin Dosage Regimen

US Patent:
2013028, Oct 31, 2013
Filed:
Apr 23, 2013
Appl. No.:
13/868612
Inventors:
Israel Hodish - Ann Arbor MI, US
International Classification:
G06F 19/00
US Classification:
702 19
Abstract:
A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.


Israel Hodish Photo 10

System For Optimizing A Patient's Insulin Dosage Regimen

US Patent:
8457901, Jun 4, 2013
Filed:
Apr 3, 2009
Appl. No.:
12/417960
Inventors:
Eran Beshan - Ann Arbor MI, US
Israel Hodish - Ann Arbor MI, US
Assignee:
Hygieia, Inc. - Ann Arbor MI
International Classification:
G01N 33/48, G01N 31/00, G06G 7/48, G06G 7/58
US Classification:
702 19, 702 22, 703 11, 703 12
Abstract:
A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.